Funding for this research was provided by:
Studienstiftung des Deutschen Volkes
Deutsche Forschungsgemeinschaft (SFB 1286/B02, - EXC 2067/1- 3907299)
Horizon 2020 Framework Programme (ERC CoG 72493)
Received: 21 July 2020
Accepted: 17 November 2020
First Online: 3 December 2020
: SOR is a shareholder of NanoTag Biotechnologies and received compensation as consultant of NanoTag Biotechnologies. There are no conflicts of interest for any of the other authors.